Xilio Therapeutics, Inc. — CORRESP Filings
7 CORRESP filings on record
This page lists all CORRESP filings submitted to the SEC by Xilio Therapeutics, Inc. (XLO), sorted by most recent first. Each row links to the full filing on EdgarLookup. Xilio Therapeutics, Inc. has filed 7 CORRESP documents with the SEC since 2021. To view all SEC filings by Xilio Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| CORRESP | — | 0001558370-25-006516 | May 6, 2025 | — |
| CORRESP | — | 0001558370-24-006565 | May 2, 2024 | — |
| CORRESP | — | 0001104659-22-119414 | Nov 16, 2022 | — |
| CORRESP | — | 0001104659-21-127590 | Oct 19, 2021 | — |
| CORRESP | — | 0001104659-21-127588 | Oct 19, 2021 | — |
| CORRESP | — | 0001104659-21-126924 | Oct 18, 2021 | — |
| CORRESP | — | 0001104659-21-122051 | Oct 1, 2021 | — |